A survey of glioblastoma genomic amplifications and deletions.
about
HAUSP, a novel deubiquitinase for Rb - MDM2 the critical regulatorDeregulated signaling pathways in glioblastoma multiforme: molecular mechanisms and therapeutic targetsNovel delivery strategies for glioblastomaTargeting oncogenic ALK and MET: a promising therapeutic strategy for glioblastomaEvaluation of tyrosine kinase inhibitor combinations for glioblastoma therapyGFAP-Cre-mediated transgenic activation of Bmi1 results in pituitary tumorsIdentification of novel SNPs in glioblastoma using targeted resequencingMalignant precursor cells pre-exist in human breast DCIS and require autophagy for survivalGenetics of glioblastoma: a window into its imaging and histopathologic variability.Relationships linking amplification level to gene over-expression in gliomasA novel approach to the discovery of survival biomarkers in glioblastoma using a joint analysis of DNA methylation and gene expression.Big Potassium (BK) ion channels in biology, disease and possible targets for cancer immunotherapy.Molecular targeting of glioblastoma: Drug discovery and therapiesMethylation of leukocyte DNA and ovarian cancer: relationships with disease status and outcome.Evolution of malignant glioma treatment: from chemotherapy to vaccines to viruses.Integrated genomic analyses identify ERRFI1 and TACC3 as glioblastoma-targeted genes.MDM2, MDMX and p53 in oncogenesis and cancer therapyIntegration of global spectral karyotyping, CGH arrays, and expression arrays reveals important genes in the pathogenesis of glioblastoma multiforme.Amplified and homozygously deleted genes in glioblastoma: impact on gene expression levelsAmplicon rearrangements during the extrachromosomal and intrachromosomal amplification process in a gliomaDistinct genomic aberrations between low-grade and high-grade gliomas of Chinese patients.Gene expression profile of glioblastoma peritumoral tissue: an ex vivo study.Imaging the delivery of brain-penetrating PLGA nanoparticles in the brain using magnetic resonance.PI3K in cancer: divergent roles of isoforms, modes of activation and therapeutic targeting.Glioblastoma-derived epidermal growth factor receptor carboxyl-terminal deletion mutants are transforming and are sensitive to EGFR-directed therapies.Maintenance of primary tumor phenotype and genotype in glioblastoma stem cells.DNA copy number analysis of Grade II-III and Grade IV gliomas reveals differences in molecular ontogeny including chromothripsis associated with IDH mutation status.Resveratrol Impairs Glioma Stem Cells Proliferation and Motility by Modulating the Wnt Signaling PathwayRapid detection of high-level oncogene amplifications in ultrasonic surgical aspirations of brain tumors.Suppression of the invasive potential of Glioblastoma cells by mTOR inhibitors involves modulation of NFκB and PKC-α signaling.Anti-cancer Therapies in High Grade Gliomas.AIB1 Genomic Amplification Predicts Poor Clinical Outcomes in Female Glioma PatientsStandards of care and novel approaches in the management of glioblastoma multiforme.The Human Glioma-Associated Oncogene Homolog 1 (GLI1) Family of Transcription Factors in Gene Regulation and Diseases.Familial glioblastoma: A case report of glioblastoma in two brothers and review of literature.Targeting PI3K in Cancer: Any Good News?Genetic alterations in glioma.Prognostic and predictive biomarkers in adult and pediatric gliomas: toward personalized treatment.Chromosomal Instability and Phosphoinositide Pathway Gene Signatures in Glioblastoma MultiformeInvestigating the therapeutic role and molecular biology of curcumin as a treatment for glioblastoma
P2860
Q24297641-6A0DE06E-99FD-49ED-9925-7F2AE73E14C6Q26829873-5F2A54F0-8E02-44B9-8923-5D1E647C13ECQ27006099-6C998E00-7CB3-4188-A096-C109DF449A26Q27022941-925FA782-3B48-4EC1-AD9D-C713854C4F85Q27320588-59D13F65-36AD-48C5-945F-0FFE360C81DDQ28730123-0D0F0A56-B190-414B-9A91-D4FE35A4E8D7Q28743773-E8F6B7A0-994C-4CA3-BF59-EF5B759327D9Q33565313-06406C9A-44E5-430F-89B2-610CD4E04AD9Q33620506-51D52710-E8FC-4457-97D6-83668374A3E2Q33775591-61D9C47D-7BCF-4CB2-A17C-1B7EC7380E8DQ33784612-D40A99F3-7FA2-4F28-B959-6C85DBD54A8CQ33802553-6F46275D-4F0A-4554-900B-DCB663770E07Q33911283-86305AD8-4056-4AB5-9239-83C740A83EE8Q33915396-CDCF3650-5E14-462B-9534-927B4B76E1ECQ33923950-0DBD43A2-2ABA-4E87-A992-FB0BFEDB0ED0Q34152192-00AC03A3-FF27-4067-ADB7-C65E131B5F83Q34166049-77643D8A-20A1-42A8-9817-DAF0013526A1Q34259262-79DD48B7-A48F-4936-A09F-BD5AFC6F3DF8Q34430791-B5A6758C-7C0E-4A17-9121-DA8D3C2A1D5CQ34579753-DA899FB7-FE8C-4210-9691-200196938E7BQ34603177-679DE286-24CA-4BAD-8254-240CFDD26ED2Q34614301-12E030A8-A4B7-4186-BB67-705829842B26Q35070535-505A4CC1-9811-4FFE-BD57-BCF9DBBFD88CQ35260766-4034FEE0-3B99-45C9-ACC1-683CA1A3BAA6Q35623965-B8ED0938-145B-4E4A-AFE1-7D1D350ADB52Q35696355-85B6C588-DD9A-4404-A9BA-F15124928843Q35760603-FD101A3B-F47D-4D57-A590-D4AA7B80E998Q36247757-0C0EA663-982D-47C8-A25D-726605DE4176Q36329368-30858932-0AC7-44A2-B97A-8A977D48D8E5Q36650919-7C3CEA52-5908-4AF9-B8D6-92FA2BD94D45Q37290626-91D766E5-A848-4AD4-AD28-91AF48774E69Q37427945-C7AD9610-7865-4CF0-B976-03CC66BFF721Q37525881-0FC21C4D-7D4A-4222-81BC-B9A646760B8EQ37814123-ADC4ECBB-D1BC-437A-AD3B-39AE9B89E804Q37964672-2EF3B81D-C5EC-42D5-A815-7EC747196B13Q38105322-55B8FB6B-9E88-4A7D-BC03-533AF21BAD90Q38161344-E4C83DC5-DC56-4D24-9D99-7424248F8FD5Q38203283-4DDBE037-B11D-4B60-A16F-9B6969DB6CD6Q38388784-3F920783-E345-4410-BFCB-FD9C05F33692Q38915880-3FFFF3AF-E02D-47E9-9438-2CC93F81AFC4
P2860
A survey of glioblastoma genomic amplifications and deletions.
description
2009 nî lūn-bûn
@nan
2009年の論文
@ja
2009年学术文章
@wuu
2009年学术文章
@zh-cn
2009年学术文章
@zh-hans
2009年学术文章
@zh-my
2009年学术文章
@zh-sg
2009年學術文章
@yue
2009年學術文章
@zh
2009年學術文章
@zh-hant
name
A survey of glioblastoma genomic amplifications and deletions.
@en
A survey of glioblastoma genomic amplifications and deletions.
@nl
type
label
A survey of glioblastoma genomic amplifications and deletions.
@en
A survey of glioblastoma genomic amplifications and deletions.
@nl
prefLabel
A survey of glioblastoma genomic amplifications and deletions.
@en
A survey of glioblastoma genomic amplifications and deletions.
@nl
P2093
P1476
A survey of glioblastoma genomic amplifications and deletions.
@en
P2093
Avadhut D Joshi
Gregory J Riggins
Jennifer Edwards
Shailaja K Rao
P2888
P304
P356
10.1007/S11060-009-9959-4
P577
2009-07-17T00:00:00Z